Prostate-specific antigen decline (PSA) as a surrogate for overall survival (OS) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) who failed first-line chemotherapy

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Halabi, S; Armstrong, AJ; Sartor, AO; De Bono, JS; Kaplan, EB; Small, EJ

Published Date

  • May 20, 2012

Published In

Volume / Issue

  • 30 / 15

Published By


  • 1

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference Location

  • Chicago, IL

Conference Start Date

  • June 1, 2012

Conference End Date

  • June 6, 2012